The Edwards Pascal Precision System is used to repair a patient’s mitral valve by lessening or stopping it from leaking. It is used on patients with severe degenerative mitral valve regurgitation.
The device is less invasive, allows for faster recovery and has fewer risks, cardiologist Kamran Muhammad, MD, said in the report.
Cardiologists implanted the device into an 84-year-old woman as part of a major study. Hillcrest Medical Center, where the Oklahoma Heart Institute is located, presented the results in September, which it said led to FDA approval this year.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
